Private Advisor Group LLC lifted its stake in Danaher Corporation (NYSE:DHR) by 5.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,917 shares of the conglomerate’s stock after purchasing an additional 971 shares during the quarter. Private Advisor Group LLC’s holdings in Danaher Corporation were worth $1,562,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. raised its position in shares of Danaher Corporation by 3.9% in the 1st quarter. Vanguard Group Inc. now owns 40,967,631 shares of the conglomerate’s stock worth $3,503,962,000 after purchasing an additional 1,530,015 shares during the last quarter. BlackRock Inc. raised its position in shares of Danaher Corporation by 2,530.9% in the 1st quarter. BlackRock Inc. now owns 37,967,922 shares of the conglomerate’s stock worth $3,247,398,000 after purchasing an additional 36,524,795 shares during the last quarter. FMR LLC raised its position in shares of Danaher Corporation by 0.3% in the 1st quarter. FMR LLC now owns 19,441,167 shares of the conglomerate’s stock worth $1,662,803,000 after purchasing an additional 53,429 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Danaher Corporation by 6.0% in the 1st quarter. Geode Capital Management LLC now owns 5,815,659 shares of the conglomerate’s stock worth $496,687,000 after purchasing an additional 329,458 shares during the last quarter. Finally, Flossbach Von Storch AG raised its position in shares of Danaher Corporation by 44.7% in the 2nd quarter. Flossbach Von Storch AG now owns 5,782,019 shares of the conglomerate’s stock worth $487,945,000 after purchasing an additional 1,785,810 shares during the last quarter. 75.69% of the stock is owned by hedge funds and other institutional investors.
In other Danaher Corporation news, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the firm’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $81.78, for a total value of $799,154.16. Following the sale, the insider now directly owns 155,520 shares of the company’s stock, valued at $12,718,425.60. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider William King sold 7,458 shares of the firm’s stock in a transaction that occurred on Friday, July 21st. The shares were sold at an average price of $82.97, for a total value of $618,790.26. Following the completion of the sale, the insider now directly owns 18,245 shares in the company, valued at $1,513,787.65. The disclosure for this sale can be found here. Over the last three months, insiders sold 71,496 shares of company stock worth $5,916,223. 12.20% of the stock is owned by corporate insiders.
Several equities analysts have recently issued reports on DHR shares. J P Morgan Chase & Co reaffirmed an “overweight” rating and issued a $95.00 price target on shares of Danaher Corporation in a research report on Friday, September 8th. BidaskClub lowered Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Saturday, July 8th. Wells Fargo & Company reaffirmed a “market perform” rating on shares of Danaher Corporation in a research report on Saturday, July 22nd. Citigroup Inc. set a $96.00 target price on Danaher Corporation and gave the stock a “buy” rating in a research report on Friday, July 21st. Finally, Royal Bank Of Canada reissued a “hold” rating and issued a $88.00 target price on shares of Danaher Corporation in a research report on Wednesday, July 12th. One investment analyst has rated the stock with a sell rating, four have given a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company’s stock. Danaher Corporation presently has an average rating of “Buy” and an average price target of $92.62.
Shares of Danaher Corporation (DHR) opened at 86.96 on Thursday. The firm’s 50 day moving average price is $85.55 and its 200-day moving average price is $84.19. The company has a market capitalization of $60.41 billion, a P/E ratio of 27.76 and a beta of 1.03. Danaher Corporation has a 1-year low of $75.71 and a 1-year high of $88.62.
Danaher Corporation (NYSE:DHR) last posted its earnings results on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, topping the consensus estimate of $0.97 by $0.02. The firm had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. Danaher Corporation’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period last year, the company earned $0.90 earnings per share. Analysts expect that Danaher Corporation will post $3.96 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 29th will be issued a $0.14 dividend. This represents a $0.56 annualized dividend and a yield of 0.64%. The ex-dividend date of this dividend is Thursday, September 28th. Danaher Corporation’s payout ratio is currently 17.83%.
ILLEGAL ACTIVITY NOTICE: This article was reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this article on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark laws. The original version of this article can be read at https://www.com-unik.info/2017/10/12/danaher-corporation-dhr-stake-boosted-by-private-advisor-group-llc.html.
Danaher Corporation Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
What are top analysts saying about Danaher Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Danaher Corporation and related companies.